CunninghamTJ, GreensteinJI, LoewensternJ, DegermentzidisE, YaoL. Anti-inflammatory peptide regulates supply of heat shock protein 70 monomers: Implications for aging and age-related disease. Rejuvenation Res, 2014; Dec8 [Epub ahead of print].
2.
GeerlingsMI, JonkerC, BouterLM, AdèrHJ, SchmandB. Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition. Am J Psychiatry, 1999; 156:531–537.
3.
HarmanD. Alzheimer's disease pathogenesis: Role of aging. Ann NY Acad Sci, 2006; 1067:454–460.
4.
De LacosteMC, WhiteCL3rd. The role of cortical connectivity in Alzheimer's disease pathogenesis: A review and model system. Neurobiol Aging, 1993; 14:1–16.
5.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr, KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute onAging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 2011; 7:263–269.
6.
DasguptaB, MilbrandtJ. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci USA, 2007; 104:7217–7222.
7.
KwonKJ, KimHJ, ShinCY, HanSH. Melatonin potentiates the neuroprotective properties of resveratrol against beta-amyloid-induced neurodegeneration by modulating AMP-activated protein kinase pathways. J. Clin Neurol, 2010; 6:127–137.
8.
LiX, ZhouM, WangX, JiMH, ZhouZQ, YangJJ. Resveratrol pretreatment attenuates the isoflurane-induced cognitive impairment through its anti-inflammation and -apoptosis actions in aged mice. J Mol Neurosci, 2014; 52:286–293.
HwangJT, KwonDY, YoonSH. AMP-activated protein kinase: A potential target for the diseases prevention by natural occurring polyphenols. N Biotechnol, 2009; 26:17–22.
